Raphael Pharmaceutical (RAPH) Assets Average (2021 - 2025)
Raphael Pharmaceutical (RAPH) reported Assets Average of $30000.0 for Q4 2025, down 23.08% on a YoY basis from $39000.0 in Q4 2024, and up 62.16% sequentially from $18500.0 in Q3 2025.
Raphael Pharmaceutical (RAPH) Assets Average (2021 - 2025) Analysis & Trends
Raphael Pharmaceutical (RAPH) has 5 years of Assets Average data on file, last reported at $30000.0 in Q4 2025.
- For the quarter ending Q4 2025, Assets Average fell 23.08% year-over-year to $30000.0; the trailing twelve-month figure through Dec 2025 stood at $30000.0 (down 23.08% YoY), and the FY2025 full-year result was $40000.0, down 69.92% from the prior year.
- Assets Average grew to $30000.0 in Q4 2025, from $18500.0 in the prior quarter.
- In the past five years, Assets Average ranged from a high of $321000.0 in Q4 2023 to a low of $18500.0 in Q3 2025.
- A 5-year average of $171147.1 and a median of $188000.0 in 2022 frame the typical range for Assets Average.
- Peak annual rise in Assets Average reached 78.81% in 2024, while the deepest fall reached 87.85% in 2024.
- Tracing RAPH's Assets Average over 5 years: stood at $242000.0 in 2021, then retreated by 6.2% to $227000.0 in 2022, then surged by 41.41% to $321000.0 in 2023, then plunged by 87.85% to $39000.0 in 2024, then dropped by 23.08% to $30000.0 in 2025.
- Business Quant data shows RAPH's Assets Average at $30000.0 in Q4 2025, $18500.0 in Q3 2025, and $61500.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Raphael Pharmaceutical | 27.37 Mn | 27.33 Mn | - | 30,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30,000.00 |
| Sep 30, 2025 | 18,500.00 |
| Jun 30, 2025 | 61,500.00 |
| Mar 31, 2025 | 60,000.00 |
| Dec 31, 2024 | 39,000.00 |
| Sep 30, 2024 | 89,500.00 |
| Jun 30, 2024 | 240,500.00 |
| Mar 31, 2024 | 296,000.00 |
| Dec 31, 2023 | 321,000.00 |
| Sep 30, 2023 | 261,000.00 |
| Jun 30, 2023 | 134,500.00 |
| Mar 31, 2023 | 241,500.00 |
| Dec 31, 2022 | 227,000.00 |
| Sep 30, 2022 | 158,500.00 |
| Jun 30, 2022 | 188,000.00 |
| Mar 31, 2022 | 301,000.00 |
| Dec 31, 2021 | 242,000.00 |